Enhanced megakaryocyte and erythroid development from normal human CD34+ cells: Consequence of enforced expression of SCL

Blood

Volumn 91, Issue 10, 1998, Pages 3756-3765

  Elwood, Ngaire J ^a   Zogos, Helen ^b   Pereira, Daniel S ^b   Dick, John E ^b   Begley, C Glenn ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; CELL PROLIFERATION; COLONY FORMING UNIT GM; ERYTHROPOIESIS; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; PRIORITY JOURNAL;

EID: 0032525313     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3756.3756_3756_3765     Document Type: Article

References (70)

1. Garrell J, Campuzano S: The helix-loop-helix domain: A common motif for bristles, muscles and sex. Bioessays 13:493, 1991
2. Kadesch T: Consequences of heteromeric interactions among helix-loop-helix proteins. Cell Growth Differ 4:49, 1993
3. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987, 1987
4. Edmondson DG, Olson EN: Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem 268:755, 1993
5. Ludolph DC, Konieczny SF: Transcription factor families: Muscling in on the myogenic program. FASEB J 9:1595, 1995
6. Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H: Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268:836, 1995
7. Begley CG, Aplan PD, Denning SM, Haynes BF, Waldmann TA, Kirsch IR: The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 86:10128, 1989
8. Brown L, Cheng JT, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer R: Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMB0 J 9:3343, 1990
9. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D: Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6:1477, 1991
10. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR: Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327, 1992
11. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R: Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood 86:666, 1995
12. Ono Y, Fukuhara N, Yoshie O: Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem 272:4576, 1997
13. Elwood NJ, Cook WD, Metcalf D, Begley CG: SCL, the gene implicated in human T-cell leukemia is oncogenic in a murine T-lymphocyte cell line. Oncogene 8:3093, 1993
14. Kelliher MA, Seldin DC, Leder P: Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J 15:5160, 1996
15. Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH: Protein dimerization between Lmo2 (Rbtn2) and Tal 1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J 15:1021, 1996
16. Condorelli GL, Facchiano F, Valtieri M, Proietti E, Vitelli L, Lulli V, Huebner K, Peschle C, Croce CM: T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res 56:5113, 1996
17. Visvader J, Begley CG, Adams JM: Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene 6:187, 1991
18. Green AR, Salvaris E, Begley CG: Erythroid expression of the 'helix-loop-helix' gene, SCL. Oncogene 6:475, 1991
19. Green AR, Lints T, Visvader J, Harvey R, Begley CG: SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene 7:653, 1992
20. Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainchenker W, Mathieu-Mahul D: Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81:647, 1993
21. Kallianpur AR, Jordan JE, Brandt SJ: The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:1200, 1994
22. Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D, Mason DY: Expression of TAL-1 proteins in human tissues. Blood 85:675, 1995
23. Robb L, Lyons I, Li RL, Hartley L, Kontgen F, Harvey RP, Metcalf D, Begley CG: Absence of yolk sac hematopoiesis from mice with a targeted disruption of the SCL gene. Proc Natl Acad Sci USA 92:7075, 1995
24. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432, 1995
25. Robb L, Elwood NJ, Elefanty AG, Kontgen F, Li R, Barnett LD, Begley CG: The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 15:4123, 1996
26. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH: The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86:47, 1996
27. Apian PD, Nakahara K, Orkin SH, Kirsch IR: The SCL gene product: A positive regulator of erythroid differentiation. EMBO J 11:4073, 1992
28. Miller BA, Floras J, Cheung JY, Wojchowski DM, Bell L, Begley CG, Elwood NJ, Kreider J, Christian C: Steel factor affects SCL expression during normal erythroid differentiation. Blood 84:2971, 1994
29. Murrell AM, Bockamp E-O, Gottgens B, Chan YS, Cross MA, Hey worth CM, Green AR: Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation. Oncogene 11:131, 1995
30. Green AR, Rockman S, DeLuca E, Begley CG: Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: A novel experimental model for hemopoietic lineage restriction. Exp Hematol 21:525, 1993
31. Tanigawa T, Elwood N, Metcalf D, Cary D, DeLuca E, Nicola NA, Begley CG: The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proc Natl Acad Sci USA 90:7864, 1993
32. Tanigawa T, Nicola N, McArthur GA, Strasser A, Begley CG: Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: The effect of enforced expression of the SCL transcription factor. Blood 85:379, 1995
33. Hoang T, Paradis E, Brady G, Billia F, Nakahara K, Iscove NN, Kirsch IR: Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood 87:102, 1996
34. Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C: Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade. Mol Cell Biol 17:2954, 1997
35. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
36. Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, Grosveld G, Nienhuis AW: Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 6:1203, 1995
37. Bowtell DD, Johnson GR, Kelso A, Cory S: Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol Biol Med 4:229, 1987
38. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
39. Bender MA, Palmer TD, Gelinas RE, Miller AD: Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 61:1639, 1987
40. Elwood NJ, Zogos H, Willson T, Begley CG: Retroviral transduction of human progenitor cells: Use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro. Blood 88:4452, 1996
41. Begley CG, Basser R, Mansfield R, Thomson B, Parker WRL, Layton J, To B, Cebon J, Sheridan WP, Fox RM, Green MD: Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of SCF plus G-CSF to humans. Blood 90:3378, 1997
42. Krause DS, Fackler MJ, Civin CI, May WS: CD34: Structure, biology, and clinical utility. Blood 87:1, 1996
43. - hematopoietic stem cells. Blood 83:1515, 1994
44. Schmitt C, Ktorza S, Sarun S, Verpilleux M-P, Blanc C, Deugnier M-A, Dalloul A, Debre P: CD34-positive early stages of human T-cell differentiation. Leuk Lymphoma 17:43, 1995
45. - subpopulation from mobilized peripheral blood. Blood 85:368, 1995
46. lo marrow cells. Blood 86:548, 1995
47. Rasko JEJ, Metcalf D, Rossner MT, Begley CG, Nicola NA: The flt3/flk-2 ligand: Receptor distribution and action on murine hematopoietic cell survival and proliferation. Leukemia 9:2058, 1995
48. Begley CG, Rasko JEJ, Curtis D, Takagi K, Metcalf D, Hilton D, Roberts B, Nicola NA, Rossner MT: Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal. Exp Hematol 24:1247, 1996
49. Begley CG: Human progenitor cell assays, in Morstyn G, Sheridan W (eds): Cell Therapy. Cambridge, UK, Cambridge, 1996
50. Rasko JEJ, O'Flaherty E, Begley CG: Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/ macrophage progenitors. Stem Cells 15:33, 1997
51. Metcalf D: Clonal Culture of Hemopoietic Cells: Techniques and Applications. Amsterdam, The Netherlands, Elsevier, 1984
52. Worthington RE, Bossie-Codreanu J, Van Zant G: Quantitation of erythroid differentiation in vitro using a sensitive colorimetric assay for hemoglobin. Exp Hematol 15:85, 1987
53. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992
54. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418, 1992
55. Lu M, Maruyama M, Zhang N, Levine F, Friedmann T, Ho AD: High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor. Hum Gene Ther 5:203, 1994
56. Leroy-Viard K, Vinit M-A, Lecointe N, Jouault H, Hibner U, Romeo P-H, Mathieu-Mahul D: Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBOJ 14:2341, 1995
57. Metcalf D: The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27, 1989
58. Testa NG, Dexter TM: Cell lineages in haemopoiesis: Comments on their regulation. Semin Immunol 2:167, 1990
59. Kaushansky K: Thrombopoietin-Understanding and manipulating platelet production. Annu Rev Med 48:1, 1997
60. Migliaccio AR, Vannucchi AM, Migliaccio G: Molecular control of erythroid differentiation. Int J Hematol 64:1, 1996
61. Visvader JE, Elefanty AG, Strasser A, Adams JM: GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J 11:4557, 1992
62. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/ MGDF in megakaryocyte development. Cell 81:695, 1995
63. Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largman C, Humphries RK: Overexpression of HOXA 10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 17:495, 1997
64. Visvader JE, Crossley M, Hill J, Orkin SH, Adams JM: The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol Cell Biol 15:634, 1995
65. Green AR, DeLuca E, Begley CG: Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J 10:4153, 1991
66. Brady G, Billia F, Knox J, Hoang T, Kirsch IR, Voura EB, Hawley RG, Gumming R, Buchwald M, Siminovitch K, Miyamoto N, Boehmelt G, Iscove NN: Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol 5:909, 1995
67. Kulessa H, Frampton J, Graf T: GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 9:1250, 1995
68. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 86:2494, 1995
69. Ku H, Yonemura Y, Kaushansky K, Ogawa M: Thrombopoietin, the ligand for the Mpl receptor, synergizes with Steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544, 1996
70. Green T: Haematopoiesis. Master regulator unmasked. Nature 383:575, 1996